Physicians
Overview
Cellvizio system
Education
Reimbursement
GastroEnterology
Barrett’s Esophagus
Pancreatic Cysts
Gastric Disease
Inflammatory Bowel Disease
Bilio-Pancreatic Strictures
Colorectal Lesions
Pulmonology
Lung Nodules
Covid-19
Urology
Researchers
Overview
System
Dual Band
Microprobes
Applications
Introduction
Cancer and disease development
Drug discovery and development
Stem cells
Peripheral nerve imaging
Resources
Brochures
Application notes
Technical documents
Webinars and videos
List of publications
Investors
About us
Our story
Team
Board of Directors
Leadership
Join Us
Commercial Network
News & events
US
INT
FR
US
INT
FR
Contact
Search
Search
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
OK
News - Cellvizio
-
Mar 20, 2019
Financial results for the full year ended December 31, 2018
READ THE COMPLETE PRESS RELEASE
You might also like to read
NEWS - Cellvizio
Jun 24, 2020
Mauna Kea Technologies Announces the Launch of a First in Human Study Combining Robotic Navigational Bronchoscopy and Needle-Based Confocal Laser Endomicroscopy
Discover
NEWS - Cellvizio
May 26, 2020
Cellvizio® Endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) as a Safe and Effective Diagnostic Tool
Discover
NEWS - Cellvizio
Mar 3, 2020
Mauna Kea Technologies Receives FDA Clearance and CE Marking For Its Next-Generation Cellvizio® Platform
Discover
